Interestingly, modulation of matrix metallopeptidase 9 (MMP9) caused an improvement in sociability and social recognition memory, along with a reduction in anxiety in AD mouse model, supporting the notion that targeting MMP9 could serve as a therapeutic strategy in restoring the neurobehavioral damage in AD (Ringland et al., 2021). This evidence concerns the gene MMP9 and Alzheimer disease.